Legal Opinion
Alcon, Inc. v. TEVA PHARMACEUTICALS USA, INC.
District Court, D. Delaware
Decided October 19, 2009No. Civ. 06-234-SLRPublishedCited by 6 opinions
1Opinion of the Court
OPINION
SUE L. ROBINSON, District Judge.
I. INTRODUCTION
This action arises out of the filing of an Abbreviated New Drug Application (“ANDA”) 1 by defendant Teva Pharmaceuticals USA, Inc. (“Teva”) to market a generic version of the antibacterial drug VIGAMOX® proprietary to plaintiffs Alcon, Inc., and Alcon Manufacturing, Ltd. (now part of Alcon Research, Ltd.) 2 (collectively, “Alcon”). VIGAMOX® is a topical ophthalmic solution comprised of the active ingredient moxifloxacin hydrochloride, which is protected by, inter alia, U.S. Patent No. 6,716,830 (“the 830 patent”). Teva’s ANDA asserts a…
2Cases cited48 opinions
- Graham v. John Deere Co. of Kansas CitySupreme Court of the United States · 1966
- Edward H. Phillips v. Awh Corporation, Hopeman Brothers, Inc., and Lofton Corporation, Defendants-CrossCourt of Appeals for the Federal Circuit · 2006
- KSR International Co. v. Teleflex Inc.Supreme Court of the United States · 2007
- Renishaw Plc v. Marposs Societa' Per Azioni and Marposs CorporationCourt of Appeals for the Federal Circuit · 1998
- United States v. AdamsSupreme Court of the United States · 1966
43 more not listed; retrieve them via the Exa API.
3Cited by6 opinions
- Bristol-Myers Squibb Co. v. Teva Pharmaceuticals USA, Inc.District Court, D. Delaware · 2013
- B. Braun Melsungen Ag v. Terumo Medical Corp.District Court, D. Delaware · 2010
- Eli Lilly and Co. v. Actavis Elizabeth LLCDistrict Court, D. New Jersey · 2009
- Galderma Labs., L.P. v. Amneal Pharm., LLCDistrict Court, D. Delaware · 2018
- Bristol-Myers Squibb Company v. Aurobindo Pharma USA Inc.District Court, D. Delaware · 2020
1 more not listed; retrieve them via the Exa API.